| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |